糖尿病大血管并发症相关动物模型的构建与应用进展

杨玉洁 ,  张莉莉 ,  潘昕昀 ,  丁英鹏 ,  王中群

中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (8) : 1127 -1134.

PDF (504KB)
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (8) : 1127 -1134. DOI: 10.12092/j.issn.1009-2501.2026.08.013
综述与讲座

糖尿病大血管并发症相关动物模型的构建与应用进展

作者信息 +

Advances in the construction and application of animal models for diabetic macrovascular complications

Author information +
文章历史 +
PDF (516K)

摘要

糖尿病大血管并发症是糖尿病患者致残和死亡的主要原因,其核心病理特征在于长期代谢紊乱背景下动脉粥样硬化的加速进展及斑块不稳定性增加。动物模型在阐明糖尿病大血管并发症的发病机制及评价防治措施中具有重要作用。本文围绕糖尿病冠状动脉疾病、脑血管病变及外周动脉疾病等主要类型,对饮食诱导、化学诱导、基因修饰及联合干预等常用动物模型的构建方法、病理特征及应用现状进行综述,比较不同模型在模拟疾病表型和研究适用性方面的差异,并分析其局限性。旨在为糖尿病大血管并发症动物模型的合理选择与改进提供参考依据。

Abstract

Diabetes-associated macrovascular complications constitute a principal source of disability and mortality among individuals with diabetes. The defining pathological hallmark of these complications is the accelerated development of atherosclerosis accompanied by heightened plaque instability, arising in the context of chronic metabolic dysregulation. Animal models are therefore indispensable for elucidating the underlying mechanisms of diabetic macrovascular disease and for rigorously assessing preventive and therapeutic interventions. This review concentrates on the major manifestations of diabetic macrovascular pathology, including coronary artery disease, cerebrovascular disease, and peripheral arterial disease. It provides a systematic synthesis of the construction strategies, pathological features, and current research applications of widely used animal models, encompassing diet-induced, chemically induced, genetically modified, and combined-intervention approaches. In addition, the review offers a comparative evaluation of these models with respect to their capacity to recapitulate disease phenotypes and their suitability for addressing specific research questions, while also critically examining their methodological limitations. Collectively, this work aims to inform the rational selection and refinement of animal models for the study of diabetic macrovascular complications.

关键词

关键词 糖尿病大血管并发症 / 动脉粥样硬化 / 动物模型

Key words

KEYWORDS diabetes-associated macrovascular complications / atherosclerosis / animal model

引用本文

引用格式 ▾
杨玉洁,张莉莉,潘昕昀,丁英鹏,王中群. 糖尿病大血管并发症相关动物模型的构建与应用进展[J]. 中国临床药理学与治疗学, 2026, 31(8): 1127-1134 DOI:10.12092/j.issn.1009-2501.2026.08.013

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021[J].Lancet, 2023, 402(10397): 203-234.

[2]

Yu MG, Gordin D, Fu J, et al. Protective factors and the pathogenesis of complications in diabetes[J].Endocr Rev, 2024, 45(2): 227-252.

[3]

Hamrangsekachaee M, Wen K, Bencherif SA, et al. Atherosclerosis and endothelial mechanotransduction: current knowledge and models for future research[J].Am J Physiol Cell Physiol, 2023, 324(2): C488-C504.

[4]

Khan AW, Jandeleit-Dahm KAM. Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches[J].Nat Rev Cardiol, 2025, 22(7): 482-496.

[5]

Litwak KN, Cefalu WT, Wagner JD. Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys[J].Metabolism, 1998, 47(8): 947-954.

[6]

Lv Y, Li K, Wang S, et al. Protective role of arachidonic acid against diabetic myocardial ischemic injury: a translational study of pigs, rats, and humans[J].Cardiovasc Diabetol, 2024, 23: 58.

[7]

Tan MY, Xia B, Xiao Z, et al. Development of a new model for acute myocardial infarction in rabbits[J].J Vet Med Sci, 2017, 79(3): 467-473.

[8]

Xie SY, Liu SQ, Zhang T, et al. USP28 serves as a key suppressor of mitochondrial morphofunctional defects and cardiac dysfunction in the diabetic heart[J].Circulation, 2024, 149(9): 684-706.

[9]

Zhao Y, Li W, Zhang D.Gycyrrhizic acid alleviates atherosclerotic lesions in rats with diabetes mellitus[J].Mol Med Rep, 2021, 24(5): 755.

[10]

Chablais F, Jaźwińska A.Induction of myocardial infarction in adult zebrafish using cryoinjury[J].J Vis Exp, 2012(62): e3666.

[11]

Charlot A, Bringolf A, Mallard J, et al. Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet[J].Front Nutr, 2024, 11: 1366883.

[12]

Cooper MA, O'Meara B, Jack MM, et al. Intrinsic activity of C57BL/6 substrains associates with high-fat diet-induced mechanical sensitivity in mice[J].J Pain, 2018, 19(11): 1285-1295.

[13]

Jin Y, Kozan D, Anderson JL, et al. A high-cholesterol zebrafish diet promotes hypercholesterolemia and fasting-associated liver triglycerides accumulation[J].bioRxiv, 2023: 2023.11. 01.565134.

[14]

Ebert MLA, Schmidt VF, Öcal O, et al. A minimally invasive animal model of atherosclerosis and neointimal hyperplasia for translational research[J].Eur Radiol Exp, 2025, 9(1): 14.

[15]

Li M, Delafontaine P, Sukhanov S.Coronary atherosclerotic plaque composition and classification in hypercholesterimic pigs[J].bioRxiv, 2025: 2025.06. 06.658319.

[16]

Jia L, Qu P, Zhao Y, et al. Tripeptide DT-109 (gly-gly-leu) attenuates atherosclerosis and vascular calcification in nonhuman primates[J].Signal Transduct Target Ther, 2025, 10(1): 122.

[17]

Xiong L, Diwakarla S, Chatzis R, et al. Acute exposure to high-fat diet impairs ILC3 functions and gut homeostasis[J].Immunity, 2025, 58(5): 1185-1200. e8.

[18]

Zhang Z, Xu Y, Pang K, et al. Microbiota humanization drives human-like metabolic and immune transcriptomic shifts in pigs[J].iMetaOmics, 2025, 2(3): e70034.

[19]

Nan G, Wang B, Lv X, et al. Effects of rhaponticum carthamoides (willd.) iljin on endothelial dysfunction and the inflammatory response in type 2 diabetes mellitus mice[J].Phytomedicine, 2024, 135: 156134.

[20]

Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas[J].Physiol Res, 2001, 50(6): 537-546.

[21]

Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes[J].Diabetologia, 2008, 51(2): 216-226.

[22]

Akinlade OM, Owoyele BV, Soladoye AO.Streptozotocin-induced type 1 and 2 diabetes in rodents: a model for studying diabetic cardiac autonomic neuropathy[J].Afr Health Sci, 2021, 21(2): 719-727.

[23]

Liu C, Wu K, Gao H, et al. Current strategies and potential prospects for nanoparticle-mediated treatment of diabetic nephropathy[J].Diabetes Metab Syndr Obes, 2022, 15: 2653-2673.

[24]

Zhou L, Yao S.Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications[J].Mol Biomed, 2023, 4(1): 10.

[25]

Ge X, Wang S, Li Z, et al. Lactate-activated GPR132-src signal induces macrophage senescence and aggravates atherosclerosis under diabetes[J].Adv Sci (Weinh), 2025, 12(33): e00141.

[26]

Shamsuzzaman S, Deaton RA, Salamon A, et al. Novel mouse model of myocardial infarction, plaque rupture, and stroke shows improved survival with myeloperoxidase inhibition[J].Circulation, 2024, 150(9): 687-705.

[27]

Wu LD, Shi Y, Kong CH, et al. The GRK2/AP-1 signaling axis mediates vascular endothelial dysfunction and atherosclerosis induced by oscillatory low shear stress[J].Adv Sci (Weinh), 2025, 12(33): e01981.

[28]

Yun Y, Zhang C, Guo S, et al. Identification of betulinic acid derivatives as potent TGR5 agonists with antidiabetic effects via humanized TGR5H88Y mutant mice[J].J Med Chem, 2021, 64(16): 12181-12199.

[29]

Bae H, Jung S, Le J, et al. Cross-organ metabolite production and consumption in healthy and atherogenic conditions[J].Cell, 2025, 188(16): 4441-4455. e16.

[30]

Musunuru K, Chadwick AC, Mizoguchi T, et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates[J].Nature, 2021, 593(7859): 429-434.

[31]

Jin H, Zhang C, Nagenborg J, et al. Genome-scale metabolic network of human carotid plaque reveals the pivotal role of glutamine/glutamate metabolism in macrophage modulating plaque inflammation and vulnerability[J].Cardiovasc Diabetol, 2024, 23(1): 240.

[32]

Goutchtat R, Quenon A, Clarisse M, et al. Effects of subtotal pancreatectomy and long-term glucose and lipid overload on insulin secretion and glucose homeostasis in minipigs[J].Endocrinol Diabetes Metab, 2023, 6(4): e425.

[33]

Zhang WX, Tai GJ, Li XX, et al. Inhibition of neointima hyperplasia by the combined therapy of linagliptin and metformin via AMPK/Nox4 signaling in diabetic rats[J].Free Radic Biol Med, 2019, 143: 153-163.

[34]

Kashyap S, Engel S, Osman M, et al. Cardiovascular manifestations of renovascular hypertension in diabetic mice[J].PeerJ, 2016, 4: e1736.

[35]

Bao XL, Dai Y, Lu L, et al. Vasostatin-2 associates with coronary collateral vessel formation in diabetic patients and promotes angiogenesis via angiotensin-converting enzyme 2[J].Eur Heart J, 2023, 44(19): 1732-1744.

[36]

Jia Y, Zhao Y, Niu M, et al. Preliminary study of metabolomic changes during the progression of atherosclerosis in miniature pigs[J].Animal Model Exp Med, 2024, 7(4): 419-432.

[37]

Leaver HA, Craig SR, Yap PL, et al. Lymphocyte responses following open and minimally invasive thoracic surgery[J].Eur J Clin Invest, 2000, 30(3): 230-238.

[38]

Rostami N, Gomari MM, Choupani E, et al. Exploring advanced CRISPR delivery technologies for therapeutic genome editing[J].Small Sci, 2024, 4(10): 2400192.

[39]

Ma H, Xu J, Fang H, et al. A capsule-based scaffold incorporating decellularized extracellular matrix and curcumin for islet beta cell therapy in type 1 diabetes mellitus[J].Biofabrication, 2024, 16(4): 045038.

[40]

Cole JB, Florez JC.Genetics of diabetes mellitus and diabetes complications[J].Nat Rev Nephrol, 2020, 16(7): 377-390.

[41]

Kalaria RN, Akinyemi R, Ihara M.Stroke injury, cognitive impairment and vascular dementia[J].Biochim Biophys Acta Mol Basis Dis, 2016, 1862(5): 915-925.

[42]

Li W, Qu Z, Prakash R, et al. Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic goto-kakizaki rats[J].Brain Res, 2013, 1541: 106-114.

[43]

Ngwa C, Al Mamun A, Qi S, et al. Central IRF4/5 signaling are critical for microglial activation and impact on stroke outcomes[J].Transl Stroke Res, 2024, 15(4): 831-843.

[44]

Patel RB, Dhanesha N, Sutariya B, et al. Targeting neutrophil α9 improves functional outcomes after stroke in mice with obesity-induced hyperglycemia[J].Stroke, 2023, 54(9): 2409-2419.

[45]

Ganbaatar B, Fukuda D, Shinohara M, et al. Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice[J].Eur J Pharmacol, 2020, 875: 173040.

[46]

Yaksh TL, Woller SA, Ramachandran R, et al. The search for novel analgesics: targets and mechanisms[J].F1000Prime Rep, 2015, 7: 56.

[47]

Kothari R, abdulrahim MW, oh HJ, et al. a mast cell receptor mediates post-stroke brain inflammation via a dural-brain axis[J].Cell, 2025, 188(20): 5499-5515. e20.

[48]

Bai YY, Gao X, Wang YC, et al. Image-guided pro-angiogenic therapy in diabetic stroke mouse models using a multi-modal nanoprobe[J].Theranostics, 2014, 4(8): 787-797.

[49]

Kastrup A, Engelhorn T, Beaulieu C, et al. Dynamics of cerebral injury, perfusion, and blood-brain barrier changes after temporary and permanent middle cerebral artery occlusion in the rat[J].J Neurol Sci, 1999, 166(2): 91-99.

[50]

Augestad IL, Dekens D, Karampatsi D, et al. Normalisation of glucose metabolism by exendin-4 in the chronic phase after stroke promotes functional recovery in male diabetic mice[J].Br J Pharmacol, 2022, 179(4): 677-694.

[51]

Zhu W, Davis CM, Allen EM, et al. Sex difference in capillary reperfusion after transient middle cerebral artery occlusion in diabetic mice[J].Stroke, 2023, 54(2): 364-373.

[52]

Zhang SX, Yao YH, Zhang S, et al. Comparative study of DSC-PWI and 3D-ASL in ischemic stroke patients[J].J Huazhong Univ Sci Technolog Med Sci, 2015, 35(6): 923-927.

[53]

Ma W, Wang C, Xiao J.A testlet diagnostic classification model with attribute hierarchies[J].Appl Psychol Meas, 2023, 47(3): 183-199.

[54]

Nutma E, Fancy N, Weinert M, et al. Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases[J].Nat Commun, 2023, 14(1): 5247.

[55]

Sharma S, Cheema M, Reeson PL, et al. A pathogenic role for IL-10 signalling in capillary stalling and cognitive impairment in type 1 diabetes[J].Nat Metab, 2024, 6(11): 2082-2099.

[56]

Li Y, Liu Y, Liu S, et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies[J].Signal Transduct Target Ther, 2023, 8(1): 152.

[57]

Lejay A, Wu WW, Kuntz SH, et al. What is the best experimental model for developing novel therapeutics in peripheral artery disease?[J].Arterioscler Thromb Vasc Biol, 2024, 44(11): 2264-2270.

[58]

Yang Y, Xu Q, Li T, et al. Trimetazidine ameliorates hindlimb ischaemic damage in type 2 diabetic mice[J].Ann Med, 2021, 53(1): 1099-1107.

[59]

Asadi-Yousefabad SL, Nammian P, Tabei SMB, et al. Angiogenesis in diabetic mouse model with critical limb ischemia; cell and gene therapy[J].Microvasc Res, 2022, 141: 104339.

[60]

Niu M, Liu Y, Xiang L, et al. Long-term case study of a wuzhishan miniature pig with diabetes[J].Animal Model Exp Med, 2020, 3(1): 22-31.

[61]

Cheng HS, Pérez-Cremades D, Zhuang R, et al. Impaired angiogenesis in diabetic critical limb ischemia is mediated by a miR-130b/INHBA signaling axis[J].JCI Insight, 2023, 8(10): e163041.

[62]

Yan X, Zhang H, Fan Q, et al. Dectin-2 deficiency modulates Th1 differentiation and improves wound healing after myocardial infarction[J].Circ Res, 2017, 120(7): 1116-1129.

[63]

Emini Veseli B, Perrotta P, De Meyer GRA, et al. Animal models of atherosclerosis[J].Eur J Pharmacol, 2017, 816: 3-13.

[64]

Lin JB, Phillips EH, Riggins TE, et al. Imaging of small animal peripheral artery disease models: recent advancements and translational potential[J].Int J Mol Sci, 2015, 16(5): 11131-11177.

[65]

Krishna S, Moxon J, Kraeuter AK, et al. Effect of metformin in a novel experimental model of peripheral artery disease[J].Clin Sci (Lond), 2025, 139(15): 847-856.

[66]

Singh MV, Dokun AO. Diabetes mellitus in peripheral artery disease: beyond a risk factor[J].Front Cardiovasc Med, 2023, 10: 1148040.

[67]

Wang Y, Wu H, Pan Y, et al. Innovations in hydrogel therapies for diabetic wound healing: bridging the gap between pathophysiology and clinical application[J].Burns Trauma, 2025, 13: tkaf025.

[68]

Couturier A, Calissi C, Cracowski JL, et al. Mouse models of diabetes-related ulcers: a systematic review and network meta-analysis[J].EBioMedicine, 2023, 98: 104856.

基金资助

国家自然科学基金(82370457)

江苏省重点研发计划(BE2022780)

AI Summary AI Mindmap
PDF (504KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉